The overall aim is to finish ongoing projects prior to retirement. Completion of work on the relationship between tumor antigenicity and the success of immunotherapy has top priority. Next to this, as much as possible of ongoing work on vaccination against MuLV-induced leukemias will be completed. Within the confines of time available, other ongoing experimental and theoretial projects will be concluded.
| Reif, A E (1986) Susceptibility to carcinogenesis. Cancer 57:2408-18 |
| Reif, A E (1986) Relationship of success in classical immunotherapy to the relative immunorejective strength of the tumor. J Natl Cancer Inst 77:899-908 |
| Reif, A E (1985) Vaccination of adult and newborn mice of a resistant strain (C57BL/6J) against challenge with leukemias induced by Moloney murine leukemia virus. Cancer Res 45:25-31 |
| Talmadge, J E; Uithoven, K A; Reif, A E (1985) Relationship of macrophage content, immunogenicity, and metastatic potential of a murine osteosarcoma of recent origin. Clin Exp Metastasis 3:61-72 |
